| Document Date: 2014-08-12 08:05:40
Open Document File Size: 449,89 KBShare Result on Facebook
Company BioMarin UK Ltd. / Published Specifications and Products / / Country United Kingdom / / Currency GBP / / Event Company Expansion / / IndustryTerm chemical neuro transmitter / treatment of Lambert-Eaton Myasthenic Syndrome / / MedicalCondition cancers / numbness / excessive fatigue / SCLC / especially small-cell lung cancer / cancer / Lambert Easton Myasthenic Syndrome / autoimmune disorder / learning disability / chronic progressive debilitating condition / constipation / muscle weakness / Lambert-Eaton Myasthenic Syndrome / / Organization NHSCB Board / European Medicines Agency / NHS / Commissioning Board / / Person Amifampridine (Firdapse) Amifampridine / Lambert-Eaton Myasthenic / Lambert Easton Myasthenic / / Position Care Director / Director for Trauma September / / Product 10mg / / Technology antibodies / pdf / / URL http /
SocialTag |
Clinical Commissioning Policy Statement: Amifampridine (Firdapse) for Lambert Easton Myasthenic Syndrome (LEMS) April 2013